Status:
RECRUITING
Microangiopathy in Diabetes
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Neko Health AB
Conditions:
Microangiopathy
Microvascular Complications
Eligibility:
All Genders
18-60 years
Brief Summary
This clinical trial aims to evaluate the use of a contactless and non-invasive technique to measure the properties of the skin's microcirculation and its regulatory functions in both healthy individua...
Detailed Description
This study will employ investigational devices to evaluate microvascular function and correlate it to degree of microangiopathy in persons with diabetes type 1 and healthy controls. The investigation...
Eligibility Criteria
Inclusion
- Diabetes mellitus type 1.
- Cohort specific inclusion criteria apply, please review 'groups' section.
Exclusion
- Patients unable to understand patient information due to cognitive impairment.
- Patients unable to understand patient information due to language barriers.
- Ongoing acute infection disease or inflammatory condition.
- Pregnant or breast-feeding women.
- Patients with damaged and/or scarred tissue in the areas of interest for the investigational or comparator devices.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07145567
Start Date
March 1 2024
End Date
December 1 2027
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danderyd University Hospital
Danderyd, Stockholm County, Sweden, 182 88